The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
about
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.Hepatoblastoma with pure fetal epithelial differentiation in a 10-year-old boy: A rare case report and review of the literature.Sonoporation by microbubbles as gene therapy approach against liver cancer
P2860
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@ast
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@en
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@nl
type
label
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@ast
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@en
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@nl
prefLabel
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@ast
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@en
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@nl
P2093
P2860
P921
P3181
P356
P1476
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma
@en
P2093
Justus Lieber
Jörg Fuchs
Sorin Armeanu-Ebinger
P2860
P304
P3181
P356
10.3390/IJMS16024190
P407
P5008
P577
2015-02-16T00:00:00Z